Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell cell invasion assay data shown in Fig. 2B on p. 42 and the immunofluorescence data shown in Fig. 4D on p. 44 were strikingly similar to data appearing in other articles written by different authors at different research institutes that were submitted to different journals at around the same time. Moreover, a further investigation of this paper undertaken by the Editorial Office identified a large number of overlapping data panels comparing the Transwell cell migration and invasion assay data and the scratch‐wound assay data both within and between Figs. 2 and 3, where data which were intended to have shown the results from differently performed experiments had apparently been derived from the same original source, including an overlapping section of data within the 'MEG3+mimic' panel in Fig. 3G that would be difficult to attribute to pure chance. Owing to the fact that the contentious data in the above article had already been submitted for publication at around the same time as its submission to Oncology Reports , and given an overall lack of confidence in the presented data, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 40: 39‐48, 2018; DOI: 10.3892/or.2018.6424]

[Retracted] miR‑25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma

[Retracted] MEG3/miR‐21 axis affects cell mobility by suppressing epithelial‐mesenchymal transition in gastric cancer

[Retracted] miR‐885‐5p upregulation promotes colorectal cancer cell proliferation and migration by targeting suppressor of cytokine signaling

[Retracted] Downregulation of microRNA-206 suppresses clear cell renal carcinoma proliferation and invasion by targeting vascular endothelial growth factor A

[Retracted] MicroRNA‐34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression

[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

[Retracted] miRNA‐490‐3p promotes the metastatic progression of invasive ductal carcinoma

[Retracted] Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK

[Retracted] miR‐218 functions as a tumor suppressor gene in cervical cancer

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

RETRACTION: MicroRNA-155 enhances the activation of Wnt/beta-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1 (Retraction of Vol 13, Pg 2221, 2016)

[Retracted] microRNA‐206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α‐positive ovarian cancer cells

[Retracted] Oncogenic miR-23a-5p is associated with cellular function in RCC

[Retracted] Downregulation of long non‐coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

[Retracted] MicroRNA‐145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non‐small‐cell lung cancer cells

[Retracted] MicroRNA‐509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor

[Retracted] miR‐34a is downregulated in human osteosarcoma stem‐like cells and promotes invasion, tumorigenic ability and self‐renewal capacity

[Retracted] HCV‐E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs

[Retracted] MicroRNA‐655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway

[Retracted] MicroRNA‐362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1